Home › Trial NCT00607984
Administration of High Dose Thiotepa and Melphalan With Autologous Hematopoietic Stem Cell Transplant in Children and Adolescents With Solid Tumors
- Trial IDNCT00607984
- StatusUnknown
- PhaseN/A
- Study typeInterventional
- SponsorRabin Medical Center
- Enrollment20
- Start date2006-06
- ConditionsCentral Nervous System Tumors · Tumors
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.